Interventional technology developer AngioDynamics reported lower sales in its fiscal 2011 fourth quarter and flat growth in year-end sales.
For the quarter (end-May 31), AngioDynamics had sales of $56.4 million, down 6% from the $60.3 million booked a year ago. AngioDynamics had a fourth-quarter net loss of $752,000, down from $3.7 million in net income in the same period last year.
Sales for the year were flat compared to 2010, at $216 million. The company had net income of $8.2 million, compared with $12.3 million the year before.
For 2012, the company expects net sales in the range of $217 million to $225 million, an increase of 0% to 4% over fiscal 2011 net sales, AngioDynamics said.
